Idamycin PFS
idarubicin hydrochloride
- Strength
- 1 mg/mL
- Form
- Solution
- Class
- Anthracycline Topoisomerase Inhibitor
Pfizer Laboratories Div Pfizer Inc
Listed by Hikma Pharmaceuticals USA Inc.
| Dosage form | Injection, Solution |
|---|---|
| Route | Intravenous |
| Drug class | Anthracycline Topoisomerase Inhibitor |
| Approval route | ANDA — approved generic |
| NDC code | 0143-9219 |
| FDA application | ANDA065275 |
| RxNorm concept | 1791493 |
| Package sizes listed | 1 |
| Marketed since | January 2017 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
idarubicin hydrochloride
Pfizer Laboratories Div Pfizer Inc
idarubicin hydrochloride
Pfizer Laboratories Div Pfizer Inc
idarubicin hydrochloride
Pfizer Laboratories Div Pfizer Inc
Meitheal Pharmaceuticals Inc.
Hikma Pharmaceuticals USA Inc.
Hikma Pharmaceuticals USA Inc.
Meitheal Pharmaceuticals Inc.
Hikma Pharmaceuticals USA Inc.
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.